Case File
efta-01951105DOJ Data Set 10OtherEFTA01951105
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01951105
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Jeffrey EpsteinueevacationSgmail.com]
From:
A. de Rothschild
Sent
Thur 10/31/2013 8:24:00 PM
Subject Re:
They are mostly owned directly by their bk( many in Ldn ) They were more eager to own them ,
regardless of tax issues at the time. I don t know what their outlook is.
Envoys de mon iPhone
Le 31 oct. 2013 1 21:05, "Jeffrey Epstein" <jeevacation@gmail.com> a ecrit :
what was its value? could it be combined in the share swap. ? where are the
servers located . as there could also be an advantage to the " where you are doing
biz , tax advantage"
On Thu, Oct 31, 2013 at 3:56 PM, A. de Rothschild
wrote:
He might face a problem with the financial authorities: the name was allowed to
be valued provided that nobody was claiming it. In fact, they should have told
told the suthorities that there "might " be a risk attached to it as we were already
rthreatening to sue .
For our accounting treatemcnt, i have rather been looking at "royalties".
We have until now refrained from valuing our name as an asset for mostly historical and
moral reasons. However, Wand when we manage to build a solid brand " edmond
de r " which could stand alone, then we might consider doing differently.
Envoye de mon iPhone
Le 31 oct. 2013 1 20:22, "Jeffrey Epstein" <jeevacation@gmail.com> a ecrit :
I wonder if you might be able to play with the tax and accounting
treatment if you considered the name an asset??
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
EFTA_R1_00417942
EFTA01951105
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation@gmail.com and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation@gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00417943
EFTA01951106
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
epsteinueevacationsgmail.comEmail
jeevacation@gmail.comWire Ref
refrainedRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.